DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ tumbled 10.23% to $8.51 Friday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.41% to 20,026.77 and the Dow Jones Industrial Average falling 0.37% to 44,546.08.
The stock's fall snapped a two-day winning streak.
Corbus Pharmaceuticals Holdings Inc. closed 86.25% below its 52-week high of $61.90, which the company reached on July 31st.
The stock underperformed when compared to some of its competitors Friday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 5.96% to $4.42, Fortress Biotech Inc. (FBIO) fell 2.84% to $1.71, and Viking Therapeutics Inc. $(VKTX)$ rose 3.32% to $30.48.
Trading volume (1.2 M) eclipsed its 50-day average volume of 287,311.
Data source: Dow Jones Market Data, FactSet. Data compiled February 14, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
February 14, 2025 17:24 ET (22:24 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。